KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Long-Term Investments: 2012

Historic Long-Term Investments for Novavax (NVAX) over the last 1 years, with Dec 2012 value amounting to $6.2 million.

  • Novavax's Long-Term Investments was N/A to $1.1 million in Q1 2013 from the same period last year, while for Mar 2013 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $6.2 million for FY2012, which is N/A change from last year.
  • Per Novavax's latest filing, its Long-Term Investments stood at $6.2 million for FY2012.
  • In the past 5 years, Novavax's Long-Term Investments ranged from a high of $6.2 million in FY2012 and a low of $6.2 million during FY2012.
  • In the last 1 years, Novavax's Long-Term Investments had a median value of $6.2 million in 2012 and averaged $6.2 million.